3-[(5-bromo-1-propanoyl-2,3-dihydroindol-7-yl)sulfonyl]-N-[[(3S)-2,3-dihydro-1,4-benzodioxin-3-yl]methyl]propanamide

C23H25BrN2O6S — CID 98186397

IUPAC3-[(5-bromo-1-propanoyl-2,3-dihydroindol-7-yl)sulfonyl]-N-[[(3S)-2,3-dihydro-1,4-benzodioxin-3-yl]methyl]propanamide
SMILESCCC(=O)N1CCc2cc(Br)cc(S(=O)(=O)CCC(=O)NC[C@H]3COc4ccccc4O3)c21
InChIInChI=1S/C23H25BrN2O6S/c1-2-22(28)26-9-7-15-11-16(24)12-20(23(15)26)33(29,30)10-8-21(27)25-13-17-14-31-18-5-3-4-6-19(18)32-17/h3-6,11-12,17H,2,7-10,13-14H2,1H3,(H,25,27)/t17-/m0/s1
InChIKeySQXPXXJMYZTZAR-KRWDZBQOSA-N
MW537.43 g/mol
LogP2.87
Rot. Bonds7

About 3-[(5-bromo-1-propanoyl-2,3-dihydroindol-7-yl)sulfonyl]-N-[[(3S)-2,3-dihydro-1,4-benzodioxin-3-yl]methyl]propanamide

3-[(5-bromo-1-propanoyl-2,3-dihydroindol-7-yl)sulfonyl]-N-[[(3S)-2,3-dihydro-1,4-benzodioxin-3-yl]methyl]propanamide (PubChem CID 98186397) has the molecular formula C23H25BrN2O6S and a molecular weight of 537.43 g/mol. Its IUPAC name is 3-[(5-bromo-1-propanoyl-2,3-dihydroindol-7-yl)sulfonyl]-N-[[(3S)-2,3-dihydro-1,4-benzodioxin-3-yl]methyl]propanamide.

Molecular Properties

Compound Name3-[(5-bromo-1-propanoyl-2,3-dihydroindol-7-yl)sulfonyl]-N-[[(3S)-2,3-dihydro-1,4-benzodioxin-3-yl]methyl]propanamide
PubChem CID98186397
Molecular FormulaC23H25BrN2O6S
Molecular Weight537.43 g/mol
Exact Mass536.06
IUPAC Name3-[(5-bromo-1-propanoyl-2,3-dihydroindol-7-yl)sulfonyl]-N-[[(3S)-2,3-dihydro-1,4-benzodioxin-3-yl]methyl]propanamide
SMILESCCC(=O)N1CCc2cc(Br)cc(S(=O)(=O)CCC(=O)NC[C@H]3COc4ccccc4O3)c21
InChIInChI=1S/C23H25BrN2O6S/c1-2-22(28)26-9-7-15-11-16(24)12-20(23(15)26)33(29,30)10-8-21(27)25-13-17-14-31-18-5-3-4-6-19(18)32-17/h3-6,11-12,17H,2,7-10,13-14H2,1H3,(H,25,27)/t17-/m0/s1
InChIKeySQXPXXJMYZTZAR-KRWDZBQOSA-N
XLogP2.87
TPSA102.01 Ų
H-Bond Donors1
H-Bond Acceptors6
Rotatable Bonds7
Heavy Atoms33
Complexity

Lipinski Rule of Five

1 violation

RuleValue
MW ≤ 500537.43
LogP ≤ 52.87
H-Bond Donors ≤ 51
H-Bond Acceptors ≤ 106

Analyze 3-[(5-bromo-1-propanoyl-2,3-dihydroindol-7-yl)sulfonyl]-N-[[(3S)-2,3-dihydro-1,4-benzodioxin-3-yl]methyl]propanamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of 3-[(5-bromo-1-propanoyl-2,3-dihydroindol-7-yl)sulfonyl]-N-[[(3S)-2,3-dihydro-1,4-benzodioxin-3-yl]methyl]propanamide?
The IUPAC name of 3-[(5-bromo-1-propanoyl-2,3-dihydroindol-7-yl)sulfonyl]-N-[[(3S)-2,3-dihydro-1,4-benzodioxin-3-yl]methyl]propanamide (CID 98186397) is 3-[(5-bromo-1-propanoyl-2,3-dihydroindol-7-yl)sulfonyl]-N-[[(3S)-2,3-dihydro-1,4-benzodioxin-3-yl]methyl]propanamide.
What is the SMILES notation for 3-[(5-bromo-1-propanoyl-2,3-dihydroindol-7-yl)sulfonyl]-N-[[(3S)-2,3-dihydro-1,4-benzodioxin-3-yl]methyl]propanamide?
The canonical SMILES for 3-[(5-bromo-1-propanoyl-2,3-dihydroindol-7-yl)sulfonyl]-N-[[(3S)-2,3-dihydro-1,4-benzodioxin-3-yl]methyl]propanamide is CCC(=O)N1CCc2cc(Br)cc(S(=O)(=O)CCC(=O)NC[C@H]3COc4ccccc4O3)c21.
What is the InChIKey of 3-[(5-bromo-1-propanoyl-2,3-dihydroindol-7-yl)sulfonyl]-N-[[(3S)-2,3-dihydro-1,4-benzodioxin-3-yl]methyl]propanamide?
The InChIKey is SQXPXXJMYZTZAR-KRWDZBQOSA-N. The full InChI is InChI=1S/C23H25BrN2O6S/c1-2-22(28)26-9-7-15-11-16(24)12-20(23(15)26)33(29,30)10-8-21(27)25-13-17-14-31-18-5-3-4-6-19(18)32-17/h3-6,11-12,17H,2,7-10,13-14H2,1H3,(H,25,27)/t17-/m0/s1.
What are the key properties of 3-[(5-bromo-1-propanoyl-2,3-dihydroindol-7-yl)sulfonyl]-N-[[(3S)-2,3-dihydro-1,4-benzodioxin-3-yl]methyl]propanamide?
3-[(5-bromo-1-propanoyl-2,3-dihydroindol-7-yl)sulfonyl]-N-[[(3S)-2,3-dihydro-1,4-benzodioxin-3-yl]methyl]propanamide has a molecular weight of 537.43 g/mol, XLogP of 2.87, 7 rotatable bonds, 1 hydrogen bond donors, and 6 hydrogen bond acceptors.
Where does this data come from?
All data for 3-[(5-bromo-1-propanoyl-2,3-dihydroindol-7-yl)sulfonyl]-N-[[(3S)-2,3-dihydro-1,4-benzodioxin-3-yl]methyl]propanamide is sourced from PubChem (CID 98186397), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).